Frandsen E V, Kjeldsen M, Kilian M
Department of Oral Biology, Royal Dental College, Aarhus, Denmark.
Clin Diagn Lab Immunol. 1997 Jul;4(4):458-64. doi: 10.1128/cdli.4.4.458-464.1997.
Oral Prevotella and Capnocytophaga species, regularly isolated from periodontal pockets and associated with extraoral infections, secret specific immunoglobulin A1 (IgA1) proteases cleaving human IgA1 in the hinge region into intact Fab and Fc fragments. To investigate whether these enzymes are subject to inhibition in vivo in humans, we tested 34 sera from periodontally diseased and healthy individuals in an enzyme-linked immunosorbent assay for the presence and titers of inhibition of seven Prevotella and Capnocytophaga proteases. All or nearly all of the sera inhibited the IgA1 protease activity of Prevotella buccae, Prevotella oris, and Prevotella loescheii. A minor proportion of the sera inhibited Prevotella buccalis, Prevotella denticola, and Prevotella melaninogenica IgA1 proteases, while no sera inhibited Capnocytophaga ochracea IgA1 protease. All inhibition titers were low, ranging from 5 to 55, with titer being defined as the reciprocal of the dilution of serum causing 50% inhibition of one defined unit of protease activity. No correlation between periodontal disease status and the presence, absence, or titer of inhibition was observed. The nature of the low titers of inhibition in all sera of the IgA1 proteases of P. buccae, P. oris, and P. loescheii was further examined. In size exclusion chromatography, inhibitory activity corresponded to the peak volume of IgA. Additional inhibition of the P. oris IgA1 protease was found in fractions containing both IgA and IgG. Purification of the IgG fractions of five sera by passage of the sera on a protein G column resulted in recovery of inhibitory IgG antibodies against all three IgA1 proteases, with the highest titer being for the P. oris enzyme. These finding indicate that inhibitory activity is associated with enzyme-neutralizing antibodies.
口腔普雷沃氏菌属和二氧化碳嗜纤维菌属菌种经常从牙周袋中分离出来,并与口外感染有关,它们分泌特异性免疫球蛋白A1(IgA1)蛋白酶,可在铰链区将人IgA1裂解为完整的Fab和Fc片段。为了研究这些酶在人体内是否会受到抑制,我们在酶联免疫吸附试验中检测了34份来自牙周病患者和健康个体的血清,以检测7种普雷沃氏菌属和二氧化碳嗜纤维菌属蛋白酶的抑制物的存在情况和效价。所有或几乎所有血清均抑制颊普雷沃氏菌、口普雷沃氏菌和洛氏普雷沃氏菌的IgA1蛋白酶活性。一小部分血清抑制颊龈普雷沃氏菌、龋齿普雷沃氏菌和产黑色素普雷沃氏菌的IgA1蛋白酶,而没有血清抑制黄褐二氧化碳嗜纤维菌的IgA1蛋白酶。所有抑制效价都很低,范围为5至55,效价定义为导致一个确定单位蛋白酶活性50%抑制的血清稀释倍数的倒数。未观察到牙周病状态与抑制物的存在、不存在或效价之间的相关性。进一步研究了颊普雷沃氏菌、口普雷沃氏菌和洛氏普雷沃氏菌所有血清中IgA1蛋白酶低抑制效价的性质。在尺寸排阻色谱中,抑制活性与IgA的峰体积相对应。在同时含有IgA和IgG的组分中发现对口普雷沃氏菌IgA1蛋白酶有额外抑制作用。通过将5份血清在蛋白G柱上进行纯化,得到了针对所有三种IgA1蛋白酶的抑制性IgG抗体,其中对口普雷沃氏菌酶的效价最高。这些发现表明抑制活性与酶中和抗体有关。